Oncolytics Biotech Inc.

NASDAQ:ONCY

Biotechnology

Healthcare
$0.50 +3.03%

+$0.03 today

Market cap
$50.41M
Beta
1.08
P/E (TTM)
-4.3
EPS (TTM)
-$0.32
52W Low $0.56High $1.51

Volume 0.38M

Average 1.26M

ONCY Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Oncolytics Biotech Inc.NASDAQ: ONCY

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 112.29M shares rose 32.7% year over year, ahead of the +27.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 17.1% from the prior quarter. Over 3 fiscal years it compounded at +18.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +32.7% holds above the trailing-twelve-month pace of +27.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
112.29M+17.1% QoQ
Last fiscal yearDec 2025
95.86M+25.3% YoY
LTMMar 2026
100.12M+27.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+32.7%——
1 year+25.3%——
3-year CAGR+18.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
95.86M CAD
Year-over-year change
+25.3%
4-year CAGR
+15.7%

Weighted Avg Shares vs competitors

How ONCY compares with its peers on the latest reported figures

  • ONCY's LTM Mar 2026 weighted avg shares of 100.12M shares is the highest of the 9 companies compared; the peer median is 25.68M shares.
  • Its year-over-year change of +27.6% is the 4th highest of 9, against a peer median of +12.9%.
  • Over three fiscal years its annual growth of +18.2% compares with a peer median of +26.2%.
ONCY Competitors Peer median
Weighted Avg Shares for ONCY and competitors
Company Period LTM YoY 3-year CAGR
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
ZNTLZentalis Pharmaceuticals, Inc.LTM Mar 202671.52M +0.4%+10.8%
WHWKWhitehawk Therapeutics IncLTM Mar 202668.95M +154.8%+40.1%
MGNXMacroGenics, Inc.LTM Mar 202663.24M +0.8%+0.9%
IMMXImmix Biopharma, Inc.LTM Mar 202634.62M +19.9%+33.4%
COYACoya Therapeutics, Inc.LTM Mar 202616.73M +5.9%+18.9%
CLNNClene Inc.LTM Mar 202610.33M +43.7%+44.6%
SRZNSurrozen, Inc.LTM Mar 20269.29M +179.8%+47.8%
TILInstil Bio, Inc.LTM Mar 20266.73M +3.3%+1.0%
Peer median (excluding ONCY) 25.68M+12.9%+26.2%

Competitors are the stored peer set for ONCY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue360.58K301.11K298.59K87K70K
Gross Profit(360.58K)(301.11K)(298.59K)(87K)(70K)
Gross Margin—————
Research & Development10.31M11.85M13.12M21.65M18.27M
Selling, General & Admin10.26M8.53M11.62M13.34M21.15M
Operating Expenses20.56M20.38M24.74M34.98M39.41M
Depreciation & Amortization360.58K301.11K298.59K102K96.05K
EBITDA(20.58M)(18.71M)(20.19M)(34.88M)(39.41M)
EBITDA Margin—————
Operating Income(20.93M)(20.68M)(25.04M)(34.98M)(39.41M)
Operating Margin—————
Interest Income99K528K1.33M1.2M529.64K
Interest Expense00000
Other Income / Expenses(15.88K)1.67M4.55M3.4M61.75K
Income Before Tax(20.94M)(19.01M)(20.49M)(31.58M)(39.35M)
Pre-Tax Margin—————
Income Tax Expense39.42K64.52K71.87K130K108.4K
Net Income(20.98M)(19.08M)(20.56M)(31.71M)(39.46M)
Net Margin—————
EPS (Basic)(0.49)(0.44)(0.41)(0.41)(0.41)
EPS (Diluted)(0.49)(0.44)(0.41)(0.41)(0.41)
Weighted Avg Shares53.51M58.03M67.62M76.48M95.86M
Weighted Avg Shares (Diluted)53.51M58.03M67.62M76.48M95.86M

Oncolytics Biotech Inc.

NASDAQ:ONCY

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.